Hintco strictly adheres to the principles of non-discrimination and transparency in order to ensure a high level of competition during the auction. The auction procedure is designed to be vector-neutral. Producers can therefore supply RFNBO compliant hydrogen to Hintco, regardless of the vector utilized. Hintco requires that the product is produced using renewable energy and in compliance with sustainability requirements as specified in the Performance Specifications and the Hydrogen Purchase Agreement, incl. its Annexes. In the Global Lot, Hintco will provide two HPAs: An HPA for deliveries to Germany (HPA DE) and an HPA for deliveries to the Netherlands (HPA NL). This approach is necessary to reflect (i) the distinct supply chains to the Netherlands and to Germany and (ii) the respective national regulatory frameworks and legal orders. The HPAs are beyond that identical in wording. For reasons of clarity Hintco provides a synopsis of the HPA DE and the HPA NL. The auction process will be carried out as follows: === First of all, Hintco will assess the eligibility of the candidates with regard to the subject of the auction. Interested companies must therefore submit a request to participate. === This request to participate is assessed by Hintco in two stages: first for a complete submission on time and in the correct form, then for eligibility based on defined criteria. Candidates meeting all minimum requirements will be invited to a negotiation phase (see Section 4 Conditions of Participation ). === Hintco will then invite all candidates who have submitted an eligible request to participate to a nondiscriminatory negotiation process that will take place before the submission of a bid (see Section 2 Conditions of the Bidding Phase ). === All bidders receive the same draft HPA synopsis as the basis for negotiation proposals. Negotiations aim to create a single set of HPA contract terms for the global lot, allowing for competitive bids. All bidders receive the same...
This Germany Pharmaceuticals opportunity is one most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | Hintco NG GmbH |
|---|
| Country | Germany |
|---|
| Category | Pharmaceuticals |
|---|
| Estimated value | $613.4M |
|---|
| CPV | 24111600 |
|---|
| Published | September 23, 2025 |
|---|
| Procurement stage | Request for Proposal (RFP) |
|---|
| Response due | Not specified / rolling |
|---|
| Status | Open — accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | September 17, 2026 |
|---|
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free Germany Pharmaceuticals intelligence report in your inbox
A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.